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Exit of cells from quiescence following mitogenic stimulation is highly asynchronous,
and there is a great deal of heterogeneity in the response. Even in a single, clonal
population, some cells re-enter the cell cycle after a sub-optimal mitogenic signal while
other, seemingly identical cells, do not, though they remain capable of responding to
a higher level of stimulus. This review will consider the origins of this variability and
heterogeneity, both in cells re-entering the cycle from quiescence and in the context
of commitment decisions in continuously cycling populations. Particular attention will
be paid to the role of two interacting molecular networks, namely the RB-E2F and
APC/CCDH1 “switches.” These networks have the property of bistability and it seems
likely that they are responsible for dynamic behavior previously described kinetically by
Transition Probability models of the cell cycle. The relationship between these switches
and the so-called Restriction Point of the cell cycle will also be considered.
Keywords: cell cycle variability, restriction point, bistable switches, RB-E2F switch, APC/CCDH1 switch, transition
probability, quiescence, heterogeneity
INTRODUCTION
When starved of growth factors, normal mammalian cells cease proliferating and arrest in a
quiescent state outside the cell cycle, now commonly referred to as G0 (Holley and Kiernan, 1968;
Burk, 1970). On re-addition of growth factors (typically in the form of serum), the cells resume
cycling but only after a long lag comparable to the duration of the entire cell cycle of rapidly
proliferating cells (Burk, 1970; Temin, 1971). This lag is independent of the concentration of growth
factors or serum, even though these have widespread effects on cellular growth (mass increase) and
metabolism (Temin, 1971; Brooks, 1975, 1976). Following the lag, the cells start entering S phase
asynchronously, at a rate determined by the level of growth factors (Brooks, 1975, 1976). If the
growth factors are removed again at any point, even before the end of the lag, many cells continue
on into S phase and mitosis in the absence of further stimulation (Todaro et al., 1965; Burk, 1970;
Temin, 1971; Brooks, 1976). Cells therefore appear to become committed to re-enter the cell cycle
sometime before they reach S phase. This point of commitment, after which subsequent progress
through the cell cycle becomes independent of growth factors, is known as the Restriction Point
(Pardee, 1974). For normal, growth factor-dependent cells, the Restriction Point is widely regarded
as a critical decision point that must be passed in each and every cell cycle (Planas-Silva and
Weinberg, 1997). Underscoring its importance, regulation of this transition appears to be defective
in most if not all cancers (Malumbres and Barbacid, 2009).
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In recent years there has been a great deal of progress in
understanding the molecular details of the Restriction Point –
see Pennycook and Barr (2020) for an excellent recent review.
However, what determines the timing of the Restriction Point
remains far from clear. When stimulated from quiescence,
some cells (even in clonal populations) require much higher
levels of growth factors than others to be triggered into S
phase (Brooks et al., 1984). Even with maximal stimulation,
the cells enter S phase at different times over many hours,
indicating asynchronous passage of the Restriction point (Brooks,
1975, 1976). This asynchrony and heterogeneity is often
regarded merely as a nuisance, limiting the utility of serum
starvation/refeeding as a means to synchronize the cell cycle.
However, an alternative view is that the variability may actually be
saying something about the way in which cell cycle commitment
is regulated. At the very least, understanding the origin of
the variability is essential to any complete understanding of
cell cycle regulation. In this article, some of the causes of
this variability will be explored, with a particular focus on
the RB-E2F and APC/CCDH1 bistable switches (Stallaert et al.,
2019; Pennycook and Barr, 2020). These have the property of
excitability and increasingly seem likely to lie behind key all-or-
none commitment steps in the cell cycle.
THE RB-E2F BISTABLE SWITCH
It is now widely accepted (Planas-Silva and Weinberg, 1997;
Johnson and Skotheim, 2013; Stallaert et al., 2019; Pennycook
and Barr, 2020) that passage of the Restriction Point is regulated
by the RB-E2F pathway (Figure 1). RB in this context refers
to a family of so-called pocket proteins that includes RB
itself, the product of the retinoblastoma susceptibility gene,
together with p130 and p107 (Cobrinik, 2005). RB family
proteins bind to members of the E2F family of transcription
factors, repressing the expression of E2F-target genes either
directly or through recruitment of chromatin modifiers such as
histone deacetylase (Cobrinik, 2005; Choi and Anders, 2014). Of
particular importance are E2F1-3a, needed for the expression
of many genes required for DNA synthesis and cell cycle
progression (Bertoli et al., 2013). Indeed, knock-out of these E2Fs
prevents cell cycle re-entry from quiescence (Wu et al., 2001)
while ectopic overexpression alone is sufficient to drive quiescent
cells into S phase (Johnson et al., 1993). Likewise, elimination
of E2F repression by knock-out of all three RB family members
prevents cell cycle exit into quiescence (Sage et al., 2000). For
more detail of the distinctive roles of the different Rb family
proteins, see Box 1.
Mitogenic stimulation leads to the expression of cyclin D
(Figure 1), a family of three closely related proteins, D1–D3
(in mammals) whose pattern of expression is partly cell type
specific and partly dependent on the signaling pathway (Sherr,
1995; Choi and Anders, 2014). Cyclin D1 is induced by the
RAS-MAPK pathway in particular, but also by Wnt/β-catenin,
Notch, JAK-STAT or Hedgehog signaling (Klein and Assoian,
2008; Choi and Anders, 2014). Cyclin D2 is induced by Myc
(Bouchard et al., 1999), which in turn is elevated by growth
factor stimulation. Cyclin D3 is less-well studied but is widely
expressed and may be important in lymphoid cells (Sicinska
et al., 2003). All three bind to and activate cyclin dependent
kinases 4 and 6 (CDK4,6) and, seemingly being of equivalent
activity, will be referred to collectively hereafter as Cyclin D,
for simplicity. The active CDK4,6/Cyclin D then phosphorylates
RB family proteins – its major substrates (Sherr, 1995; Choi
and Anders, 2014). The precise details of phosphorylation are
complex, and will be revisited later. For now, phosphorylation on
multiple sites (“hyperphosphorylation”) leads to dissociation of
RB proteins from E2F, allowing the latter to activate expression
of target genes (Mittnacht, 1998; Bracken et al., 2004; Choi and
Anders, 2014). Among these, cyclin E is of particular importance
(Figure 1). Following induction, cyclin E binds to CDK2. The
active CDK2-cyclin E complex then, in turn, contributes to the
hyperphosphorylation of RB, further promoting the release of
E2F, and further expression of cyclin E in a positive feedback
loop (Yao et al., 2008; Johnson and Skotheim, 2013; Weinberg,
2013; Pennycook and Barr, 2020). The targets of E2F also include
E2F1-3, contributing another positive feedback loop promoting
E2F activity (Bracken et al., 2004). In addition, elevation of
Myc activity in response to growth factor stimulation, besides
promoting expression of Cyclin D (Bouchard et al., 1999), also
directly induces expression of E2F1-3 (Leone et al., 2001) as
well as promoting E2F-mediated transcription (Leung et al.,
2008), further contributing to Cyclin E expression and RB
suppression (Figure 1).
The positive feedback loops within the RB-E2F pathway
confer the property of bistability, such that E2F activity can
only be sustained at steady-state at one of two levels: either low
(E2F-Off) or high (E2F-On) (Yao et al., 2008). Once above a
critical threshold, E2F levels will drive inexorably upwards to the
high steady state due to the positive feedback. From then on,
the level of Cyclin E-CDK2 becomes sufficient to maintain the
hyperphosphorylation of RB without the need for further input
from Cyclin D-CDK4,6. This switch is postulated to represent
passage of the Restriction Point since, after it, growth factor
stimulation, and Cyclin D expression, are no longer needed to
maintain E2F activity (Yao et al., 2008).
Experimental evidence that the RB-E2F pathway does indeed
behave as a bistable switch came from using a green fluorescent
protein (GFP)-construct under the control of the E2F1 promoter
as an E2F reporter (Yao et al., 2008). After stimulating quiescent
cells with a high level of serum growth factors, E2F activity rose
to a high level in all cells in the population, with most going
on to enter S phase. However, when stimulated with suboptimal
levels of serum, the level of E2F activity became bimodal within
the population, with some cells maintaining the low level of
the quiescent controls, while other cells in the same population
switched to a high level of E2F. This bifurcation of E2F activity
within the population showed that the RB-E2F switch was able
to convert continuous, graded levels of growth stimulation into
all-or-none responses at the cellular level. Importantly, the cells
that subsequently went on into S phase were from those that
switched to high-E2F.
That some cells switch to high E2F under suboptimal
conditions while others do not was attributed to cellular noise
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BOX 1 | Distinct roles of Rb family members in cell cycle-regulated gene expression.
Rb family members are often treated as though they were largely equivalent in function (as in Figure 1), insofar as they all bind to E2F transcription factors, and this
interaction is disrupted by CDK-mediated phosphorylation. This, however, is an oversimplification. Rb binds preferentially to the activator E2Fs (E2F1, E2F2, and
E2F3a), whereas p107 (RBL-1) and p130 (RBL-2) associate primarily with E2F4 and E2F5, which function mainly as repressors of transcription (Cobrinik, 2005).
In quiescent cells, the level of activator E2Fs is low and the expression of genes needed for entry into the cell cycle is actively and specifically repressed by E2F4, in
association with p130 (Takahashi et al., 2000; Sadasivam and DeCaprio, 2013; Schade et al., 2019). However, E2F4 and p130 do not act alone but function along
with MuvB as part of the so-called DREAM complex, made up of DP, RB-like, E2F4 (or E2F5) and MuvB (Sadasivam and DeCaprio, 2013; Schade et al., 2019). The
multi-subunit MuvB component binds to the CHR (cell cycle genes homology region) elements found in “late” cell cycle genes. This enables the DREAM complex to
suppress both late cell cycle genes as well as E2F-dependent “early” genes, in quiescence.
After mitogenic stimulation, phosphorylation of p130 by CDK4,6/cyclin D, midway through the pre-replicative lag, leads to disruption of the DREAM complex, the
dissociation of E2F4 (Schade et al., 2019) and its replacement by E2F1, E2F2, and E2F3 (Takahashi et al., 2000). This in turn allows expression of “early” cell cycle
genes. Sometime after this, MuvB (presumably still bound to the CHR elements of late cell cycle genes, maintaining suppression) is joined by BMYB (itself a product
of early gene expression) (Sadasivam and DeCaprio, 2013). The BMYB-MuvB complex in turn recruits FOXM1 which, after phosphorylation (probably by
CDK4,6/cyclin D – Anders et al., 2011) induces expression of late cell cycle genes in G2 (Sadasivam and DeCaprio, 2013).
Although p130 and the DREAM complex contribute to the suppression of cell cycle gene expression in quiescence, RB itself (which is not able to form complexes
with MuvB) appears to play a greater role (Schade et al., 2019). Quiescent cells lacking RB show a significant de-repression of cell cycle gene expression whereas
cells lacking p130 do not (Schade et al., 2019). However, cells lacking both p130 and RB show a greater de-repression of cell cycle genes than cells lacking RB only,
confirming that DREAM does play a part in suppression (Schade et al., 2019). The greater role of RB was attributed to the inhibition of the activator E2Fs (1-3) still
needed for gene expression after repression by E2F4 is relieved. Nevertheless, Takahashi et al. (2000) were unable to detect an association of RB with the cell cycle
gene promoters examined at any time after mitogenic stimulation, even after the point half-way through the pre-replicative lag when E2F4 is replaced by E2F1, E2F2
and E2F3. This is consistent more with RB sequestering the activator E2Fs away from the promoters until after its hyperphosphorylation, rather than direct promoter
repression (Cobrinik, 2005). Importantly, DREAM and RB appear to regulate the same set of genes, with little evidence for differential expression
(Schade et al., 2019).
The exact role of p107 continues to be unclear. Its level is highest in proliferating cells and it is the product of an early E2F-regulated gene switched on during entry
into the cycle from quiescence (Schade et al., 2019). It is also upregulated in cells deficient in p130 (Schade et al., 2019). Nevertheless, although p107 is able to
complex with MuvB, there was little evidence for it doing so in p130-deficient cells (Schade et al., 2019). The limited de-repression of cell cycle-regulated cells in
p130-deficient cells does not therefore seem to be due to compensatory replacement of p130 by p107 in forming the DREAM complex. It is also noteworthy that
siRNA knock-down of p107 in cells lacking both RB and p130 did not lead to any consistent, additional changes in gene expression (Schade et al., 2019). There is
no evidence therefore for a set of genes repressed specifically by p107. Evidently, the precise contribution of p107 to cell cycle regulation remains to be determined.
FIGURE 1 | The RB-E2F bistable switch, as outlined by Yao et al. (2008). RB represents the pocket protein family consisting of RB itself, p130 and p107. E2F refers
to all activator forms, namely E2F1, E2F2, and E2F3a complexed with a dimerization partner DP1 or DP2. This simplified view of the RB-E2F pathway continues to
be useful and conceptually valid. However, see Box 1 for discussion of the distinctive roles of the different RB family members that underlie the pathway.
in pathway dynamics around the threshold, due either to small
numbers of interacting molecules or to small differences in
parameter values resulting from the previous history of the cell
(size variation, for example, or local differences in cell density)
(Yao et al., 2008). Later, a stochastic version of the model
was indeed able to generate asynchronous switching within a
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population (Lee et al., 2010). Moreover, it was able to reproduce
the apparently first order kinetics of entry into S phase observed
experimentally, in which a constant fraction of the cells enters
S phase per unit time (Brooks, 1975, 1976). These kinetics had
previously been taken as evidence for the Transition Probability
model of Smith and Martin (Smith and Martin, 1973) which
proposed the existence of a rate-limiting commitment step in the
cell cycle occurring stochastically with constant probability over
time under steady-state conditions.
THE RB-E2F SWITCH AND
HETEROGENEITY IN EXIT FROM
QUIESCENCE
Although the stochastic version of the RB-E2F switch is able to
reproduce some of the observed asynchrony in entry into S phase
after stimulation from quiescence, it fails to account for other
aspects of the kinetics. In particular, the model predicts that the
lag between stimulation and cell cycle entry should depend on
the level of stimulation (Lee et al., 2010). As already indicated,
this is not the case. Rather, the lag before the first cells reach
S phase is independent of growth factor (serum) concentration,
even though the subsequent rate of entry into S phase varies
(Brooks, 1975, 1976). Moreover, when the cells are first stimulated
with a low (suboptimal) level of serum and the level raised again
at the end of the first lag, there is another lag, identical to the first,
before the rate of entry into S increases for a second time (Brooks,
1976). It is as though only a fraction of the population responded
to the first stimulus, the rest remaining in the quiescent state until
a second (higher) stimulus was able to move them out of arrest
and on toward S phase. This would imply heterogeneity, even in
a clonal population, such that some cells can respond to a low
level of growth factors whereas others cannot.
That such heterogeneity does indeed exist was shown by later
experiments in which the response to low levels of serum was
followed over a much longer period. In the original experiments
with observations limited to around 24 h, the rate of entry into S
phase after stimulation did indeed appear first-order, following
the lag, with a rate constant dependent on the level of serum.
The expectation was that all cells would eventually reach S
phase, if followed for long enough, even with very low levels
of stimulation. This, however, is not what happens. When cells
stimulated with low serum were followed over days, the rate of
entry into S phase slowed, with the fraction of cells entering
S phase reaching a plateau (Brooks et al., 1984). This was not
because the low level of serum added was “used up” since the
medium was renewed daily. Instead, it is clear that only some
cells were able to respond to the low level of serum, with those
responding doing so asynchronously, over many hours. However
if, after reaching the plateau, the serum concentration was raised
further, the previously unresponsive cells then entered S phase
(Brooks et al., 1984). Thus, the non-responsive cells had not
become incapable of responding, they merely needed a higher
level of stimulation.
Similar results were obtained when cells were followed
by timelapse microscopy rather than 3H-thymidine
autoradiography. However, in this case it was possible to
see that some of the cells triggered to divide in response to low
serum went on to divide again, in some cases several times, while
many cells in the same field failed to respond at all (Brooks et al.,
1984; Brooks and Riddle, 1988a). This might suggest an inherited
element determining sensitivity to growth factors. However,
attempts to enrich for responding cells by prolonged culture in
low serum (3 weeks) were not successful (Brooks et al., 1984).
Following such selection, the cells were no more responsive
than the controls.
Such heterogeneity within a population is not predicted by
the simple, stochastic version of the RB-E2F bistable switch (Lee
et al., 2010). Although the inclusion of stochastic noise enables
it to reproduce asynchrony in exit from quiescence, the model
predicts that all cells should eventually do so, even with low levels
of stimulation, given long enough, which (as already discussed)
is not what happens. However, a later, extended version of the
model, explicitly including a role for CDK-inhibitors such as
p21 and p27, may provide an explanation (Kwon et al., 2017).
Systematic varying of the model parameters showed that certain
ones, in particular those affecting Cyclin-CDK activity or RB-
phosphorylation status, had a marked effect on the threshold
for switching (Kwon et al., 2017). Raising the threshold makes
it more difficult to exit quiescence, increasing both the time
required and the level of stimulation needed. Such an increase
in threshold was shown to provide a compelling explanation
for the well-established observation that cells do indeed go
deeper and deeper into quiescence the longer they are starved
of mitogenic stimulation, requiring both longer to re-enter the
cycle on re-stimulation and a higher level of stimulation (Kwon
et al., 2017). Later, it was shown that raising the threshold even
further was able to account for a shift from deep quiescence to
senescence and irreversible cell cycle arrest (Fujimaki et al., 2019;
Fujimaki and Yao, 2020).
Although variation in the activation threshold of the RB-
E2F switch is able to account for different levels of quiescence,
in the published simulations the parameters are assumed (for
simplicity) to have the same values in all cells of the population
at the same time (other than stochastic noise). In practice this is
unlikely to be the case. It is more probable that some parameters
may vary within the population, even between adjacent cells,
giving them different activation thresholds for responding to
mitogenic stimulation. Of the possible parameters that might be
implicated, the levels of CDK-inhibitors such as p27 and p21
are particularly attractive candidates. Simulations showed that
these were among the strongest coarse tuners of the threshold
in the model. In keeping with this, experimentally increased
levels of p21 did indeed raise the activation threshold (Kwon
et al., 2017; Heldt et al., 2018). Moreover, levels of p27 are
known to increase in quiescence (Coats et al., 1996), and are
heterogeneous within a population, with those cells reaching S
phase after a short serum pulse being the ones with the lowest
levels (Hitomi et al., 2006). It therefore seems probable that
differences between individual cells in the levels of p27 or p21
contribute significantly to the heterogeneity in growth factor
dependence within a quiescent population. This, of course, does
not preclude the possibility that other components of the RB-E2F
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switch also contribute to the heterogeneity, such as levels of RB
family proteins.
EXIT INTO QUIESCENCE IN CYCLING
POPULATIONS
Heterogeneity is seen not only in populations of quiescent
cells responding to mitogenic stimulation. It is also a feature
of continuously cycling cells. Recent developments in live cell
imaging have enabled cell cycle transitions to be followed with
unprecedented precision in real time. Of particular value has
been the use of a fluorescent sensor based on a fragment of
human DNA helicase B (DHB) that moves from the nucleus to
the cytoplasm on phosphorylation (Spencer et al., 2013). This
was originally thought to be selective for Cyclin-dependent kinase
2 (CDK2) but later shown to be responsive to both CDK1
and CDK2, complexed with either cyclins E or A (Schwarz
et al., 2018), and is henceforth referred to here as CDK/E,A
activity. Using this sensor, CDK/E,A activity is seen to drop
rapidly at mitosis (Spencer et al., 2013), with the onset of cyclin
A destruction, as illustrated in Figure 2A. Following mitosis,
in most proliferating cells (of many different lines), CDK/E,A
activity immediately begins rising again (CDK/E,Aincreasing
cells), increasing monotonically to a peak at the next mitosis
(Figure 2A). The pattern of this increase for the majority of cells
is broadly similar but it is noteworthy that individual traces differ,
indicating a significant degree of asynchrony (Spencer et al.,
2013). The increase is driven first by cyclin E accumulation, in
conjunction with CDK2, and then by cyclin A accumulation as
it replaces cyclin E, with CDK2 later supplemented by CDK1
(Spencer et al., 2013; Barr et al., 2016; Schwarz et al., 2018).
However, as indicated in Figure 2A, in a significant minority
of cells (typically of the order of 15–30% of the population,
depending on cell type), the CDK/E,A activity fails to rise again
immediately after mitosis (CDK/E,Alow cells), either remaining
low for the remainder of the experiment or increasing again
after a variable delay, indicating the start of another cycle
(Spencer et al., 2013; Arora et al., 2017; Yang et al., 2017; Moser
et al., 2018; Min et al., 2020). These CDK/E,Alow cells have
hypophosphorylated RB and remain mitogen sensitive for re-
entry into the cycle, indicating that they are pre-Restriction Point
cells in G0 (Spencer et al., 2013; Cappell et al., 2016; Arora et al.,
2017; Moser et al., 2018). The CDK/E,Aincreasing cells, however,
appear to be committed to the next cell cycle from birth. They
already have hyperphosphorylated RB from the very start of
the cycle and are insensitive to mitogen withdrawal or MAPK
pathway inhibition (Spencer et al., 2013; Yang et al., 2017; Min
et al., 2020). Indeed, mitogen withdrawal or MAPK pathway
inhibition must be applied during the mother cell cycle to prevent
or delay cell cycle re-entry in the CDK/E,Aincreasing daughters
(Spencer et al., 2013; Yang et al., 2017; Min et al., 2020).
This bifurcation in CDK/E,A activity occurs within what is
otherwise a homogeneous population. For rapidly growing cells,
it is attributable in large part to induction and variable expression
of p21 (Spencer et al., 2013; Overton et al., 2014; Arora et al.,
2017; Barr et al., 2017; Yang et al., 2017; Moser et al., 2018;
FIGURE 2 | A representation of live cell imaging data for CDK or APC activity.
(A) Cartoon illustrating three single cell traces, aligned to anaphase, to
indicate the range of CDK/E,A activity changes shown by individual MCF10A
cells in a continuously cycling population, based on Figure 3B of Spencer
et al. (2013). Following the drop in activity after mitosis, in roughly 75% of the
cells (continuous blue line), activity immediately starts rising again to a peak at
the next mitosis (“CDK/E,Aincreasing cells”). Although not indicated here,
individual traces within this cohort, while following the same general pattern,
nevertheless show a good deal of asynchrony. In the other 25% of the cells,
activity falls to a low level (below the horizontal dotted line, at 2 h after
anaphase, in this example). In these “CDK/E,Alow cells,” activity either remains
low until the end of the experiment (continuous red line), or spontaneously
starts rising again (dotted red line) as the cell switches to the CDK/E,Aincreasing
state. (B) Cartoon of two single-cell traces to illustrate APC activity in cycling
MCF10A cells, aligned to mitosis, based on Figure 4I of Cappell et al. (2016).
APC activity rises sharply as cells enter mitosis then drops precipitously to a
very low level several hours later. The abruptness of the fall is similar in all cells,
but its timing varies, indicating considerable asynchrony between individual
cells.
Heldt et al., 2018). Thus, p21 levels are higher in the out-of-
cycle CDK/E,Alow cells and decline as cells re-enter the cycle and
switch to the CDK/E,Aincreasing state. Importantly, in populations
of rapidly proliferating cells, the dropping out of cycle marked
by the bifurcation in CDK/E,A activity is much reduced after
knockdown of p21 with siRNA or gene inactivation, supporting a
causal role for p21 in cell cycle exit (Spencer et al., 2013; Overton
et al., 2014; Barr et al., 2017; Heldt et al., 2018).
The induction of p21 in some cells but not others is, in turn,
due to a p53-mediated DNA-damage response in the mother cell,
passed on through mitosis to the daughter cells (Arora et al.,
2017; Barr et al., 2017; Yang et al., 2017; Heldt et al., 2018).
This DNA-damage response is most likely a result of replication
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stress (e.g., stalled replication forks) during S phase in the mother
cell (Harrigan et al., 2011; Lukas et al., 2011; Koundrioukoff
et al., 2013; Moreno et al., 2016). Such replication stress is a
fairly frequent (and expected) occurrence in mammalian DNA
replication, though other causes of endogenous DNA damage are
also possible. Experimentally induced replication stress or DNA-
damage in the mother cell cycle from treatment with low doses
of aphidicolin or neocarzinostatin (insufficient to cause arrest
in G2), also led to elevated levels of p21 in daughter cells and
increased exit from the cycle into the CDK/E,Alow state (Arora
et al., 2017; Barr et al., 2017; Yang et al., 2017).
Consistent with the involvement of a DNA damage response,
cells with high levels of p21 exhibit a higher frequency of DNA-
damage foci (positive for 53BP1 or γH2AX) than cells with low
p21 (Arora et al., 2017; Barr et al., 2017). In turn, the greater
the number of DNA-damage foci, the longer it takes for the cells
to re-enter the cycle and start increasing CDK/E,A activity once
more (Arora et al., 2017). Nevertheless, not all CDK/E,Alow cells
have high p21 (Spencer et al., 2013) or show DNA damage foci
(Arora et al., 2017) and it was suggested that the presence of
foci may account for only around 50% of the cells that undergo
transient arrest after mitosis (Arora et al., 2017). This raises the
possibility that the transient arrest of some cells may be due to
something other than a DNA-damage response and elevated p21.
In this connection, it is worth noting that Hs68 human fibroblasts
immortalized with hTERT, growing optimally in high serum, have
cycle times ranging from around 10–12 h to more than 95 h
(Nassrally et al., 2019). With S+ G2 being no more than 10–12 h
(the minimum cycle time), the more than 70% of cells dividing
with ages greater than 22 h would have spent longer than 10 h
in G1, a length taken (in some studies) as indicative of cell cycle
exit (Barr et al., 2017). Nevertheless, only 10–15% of proliferating
Hs68-hTERT typically show 53BP1-positive foci (Nassrally et al.,
2019), indicating that the majority of slow transits through G1
in this cell type must have been due to something other than a
DNA-damage response. This additional factor may be related to
proliferation rate per se.
In the original experiments of Spencer et al. (2013) using
MCF10A cells in full growth medium, roughly 25% of the
cells left the cycle after each mitosis into the CDK/E,Alow state
(Figure 2A). However, in later work by Overton et al. (2014)
using the same cell type, there was no such cell cycle heterogeneity
under high growth factor conditions (20 ng/ml EGF; 5% serum).
Only when growth factor stimulation was reduced fourfold
(to 5 ng/ml EGF; 1.25% serum) did cells exit the cycle after
mitosis with the frequency reported by Spencer et al. (2013).
Thus, in the original experiments, the cells may not have been
growing at quite their maximum rate, for reasons unknown,
despite being in similar high growth factor medium. This slightly
reduced growth rate may have contributed to some of the cell
cycle drop-out after mitosis, in addition to a DNA-damage
response. The lack of any bifurcation in CDK/E,A activity in a
line of MCF10A cells deleted for both alleles of p21 was taken
as evidence that the drop-out was entirely dependent on p21
(Spencer et al., 2013), as noted previously. However, the p21−/−
MCF10A cells used had acquired a reduced dependence on EGF
during their isolation (Bachman et al., 2004), compared to the
parental line, and may therefore have been less sensitive to any
slight deficiency in the growth conditions. A role for reduced
mitogenic stimulation in the bifurcation in CDK/E,A activity, in
addition to a DNA-damage response mediated by p21, cannot
therefore be ruled out.
Further support for the possible importance of growth rate
and the level of mitogenic stimulation, in contributing to the
heterogeneity in cell exit after mitosis, comes from the results
obtained with Swiss 3T3 cells. It was reported that these cells,
nominally growing optimally but with an average cycle time
of ∼30 h, showed a very high rate of cell cycle drop-out after
mitosis, with 77% of the cells passing into the CDK/E,Alow
state (Spencer et al., 2013). However, in my own laboratory,
Swiss 3T3 cells in high serum grew at twice the rate, with a
median cycle time of around 15 h, and showed no such cell
cycle heterogeneity. Rather, cell cycle drop-out was seen only
when the cells were grown in sub-optimal serum concentrations
(Brooks and Riddle, 1988a,b). It seems probable therefore that
some of the bifurcation in CDK/E,A activity seen with Swiss 3T3
cells (Spencer et al., 2013) may have been a consequence of a
suboptimal growth rate (due, perhaps to medium composition,
which was not specified), and not due solely to a stress response
to DNA damage mediated by p53-p21.
Given that mitogen reduction is known to lead to the
induction of p27 and that its expression is heterogeneous in
quiescent populations (Coats et al., 1996; Hitomi et al., 2006),
such suboptimal growth could lead to the upregulation of
p27 in some cells. This would be expected to add to the
contribution of p21 in driving the bifurcation in CDK/E,A
activity. Clearly, live cell imaging experiments looking at both
p21 and p27 simultaneously are needed to help unpick their
relative importance under different conditions, in different cell
types. Until this is done, a role for p27 in causing some of the
transient cell cycle exit into the CDK/E,Alow state, in proliferating
populations, cannot be ruled out.
BYPASS OF THE RESTRICTION POINT
IN CONTINUOUSLY CYCLING CELLS
As already discussed, in continuously cycling cells, some 15–
30% of the population typically enter the CDK/E,Alow state after
mitosis in which CDK/E,A activity fails to increase immediately
(Figure 2A). These cells are born with hypophosphorylated
RB and require mitogenic stimulation to re-enter the cycle.
For these cells, the standard Restriction Point model seems
appropriate. However, CDK/E,Aincreasing cells, the majority, have
hyperphosphorylated RB from birth and are independent of
mitogenic stimulation for continued progress through the cell
cycle. These cells are, it seems, already committed to the next
cell cycle from birth, which calls into question the idea that the
Restriction Point is a critical decision point in G1 which all cells
must pass through before continuing to the next cycle.
The key determinant of whether cells enter the
CDK/E,Aincreasing or CDK/E,Alow paths appears to be the
level of CDK4,6/D activity immediately after mitosis (Yang et al.,
2017; Min et al., 2020). This in turn depends on the levels of
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cyclin D inherited from the mother cell, along with any p21/p27.
Importantly, interruption of mitogenic signaling with a MEK
inhibitor at any point in the mother cell cycle, even for as little
as 1 h, affects the level of cyclin D attained at the end of G2
(Min et al., 2020). This is not due to a direct effect on cyclin D
expression but rather to a decrease in overall translation rate
which persists to the end of G2, whenever the pulse of MEK
inhibitor is given earlier in the cycle. Conversely, treatment of
mother cells with the CDK4,6 inhibitor palbociclib (which blocks
the cell cycle but not cell growth in mass) produces enlarged
cells with elevated translation capacity. These enlarged cells no
longer respond to transient MEK inhibition with a reduction
in the proportion of CDK/E,Aincreasing cells after mitosis (Min
et al., 2020). That Cyclin D is the critical aspect of translation
capacity was shown by knockdown of all three cyclin D genes
in mother cells with siRNA, leading to a reduced proportion
of CDK/E,Aincreasing daughter cells. Conversely, overexpression
of cyclin D1 in mother cells, increased the proportion of
CDK/E,Aincreasing daughter cells (Min et al., 2020).
These findings provide good evidence for the importance of
cyclin D levels and CDK4/D activity in driving the bifurcation in
CDK/E,A activity after mitosis. They also offer insight into two
other fundamental features of the vertebrate cell cycle. Firstly,
since sister cells would inherit identical concentrations of cyclin
D from the mother cell, along with any p21 or p27, this would lead
to similar cell cycle trajectories immediately afterward, potentially
explaining much of the well-known correlation in sibling cycle
times (Minor and Smith, 1974; Brooks et al., 1980). Secondly,
since the level of cyclin D at the end of G2 is related to overall
translation rate, large cells, with a high translational capacity,
would generate large daughter cells with high cyclin D. These
in turn would be expected to have shorter than average G1
times, providing a possible explanation for at least some of the
observed inverse correlation between cell size and G1 duration
(Shields et al., 1978; Ginzberg et al., 2018; Min et al., 2020;
Zatulovskiy and Skotheim, 2020).
THE RELATIVE CONTRIBUTIONS OF
CDK4,6/CYCLIN D AND CDK2/CYCLIN E
IN RB HYPERPHOSPHORYLATION
According to the standard model of the Restriction Point
(Planas-Silva and Weinberg, 1997; Pennycook and Barr, 2020),
CDK4,6/Cyclin D initiates phosphorylation of RB sufficient
to partially derepress E2F, leading to the expression of
cyclin E. This in turn activates CDK2 to fully phosphorylate
(hyperphosphorylate) RB, promoting further expression of cyclin
E and setting up the positive feedback loop essential to the
bistability of the RB-E2F switch (Figure 1). An ingrained notion
in this scheme is that CDK4,6/D is insufficient on its own
for full phosphorylation of RB but instead requires help from
CDK2/E, which eventually replaces it altogether. These ideas
are challenged by the observation that CDK/E,Aincreasing cells
are already mitogen independent and have fully phosphorylated
RB from birth, when CDK/E activity is at its lowest (Spencer
et al., 2013; Moser et al., 2018; Chung et al., 2019). Moreover,
treatment with the CDK4,6 inhibitor palbociclib at any point
in G1, right up to shortly before entry into S phase, reverses
RB-hyperphosphorylation rapidly and completely (Chung et al.,
2019). This is true not only of the CDK/E,Aincreasing cells in
cycling populations, but also of cells stimulated from quiescence
that had become mitogen independent (i.e., post-Restriction
Point) several hours earlier (Chung et al., 2019). Only after
entry into S phase is RB hyperphosphorylation independent of
CDK4,6/D (insensitive to palbociclib) and instead dependent
solely on CDK/E,A activity (and sensitive to a CDK2 inhibitor)
(Chung et al., 2019).
On the face of it, these observations suggest that there is
no role at all for CDK2/E activity in RB hyperphosphorylation
throughout G1, calling into question the validity of the RB-
E2F bistable switch as the basis for the Restriction Point (Yao
et al., 2008). However, the findings of Chung et al. (2019) are in
apparent conflict with compelling evidence from Narasimha et al.
(2014) that CDK4,6/cyclin D is only able to monophosphorylate
RB and that hyperphosphorylation does not occur until after the
appearance of CDK2/Cyclin E activity in “late” G1. These studies
made use of isoelectric focusing to separate unphosphorylated
RB from isoforms phosphorylated on 1, 2, 3,. . ., up to 14 sites.
Mitogen-stimulated human fibroblasts and other cell types had
only monophosphorylated RB until an abrupt shift to fully
phosphorylated RB (on 14 sites) coincident with the appearance
of CDK2/Cyclin E activity in what was described as “late”
G1 (though the timing of DNA synthesis was not shown).
The kinase responsible for the RB monophosphorylation was
confirmed as CDK4,6/cyclin D by its absence in Cyclin D
triple-knockout mouse embryo fibroblasts (lacking all three
cyclin D genes) and by its sensitivity to palbociclib and
p16 (which disrupts CDK4,6-cyclin D complexes), whereas
the hyperphosphorylation was sensitive to a CDK2-inhibitor.
Remarkably, the monophosphorylated RB was phosphorylated
on any one, but only one, of 14 different sites. The different
monophosphorylated RB isoforms differed slightly in their
affinity for different E2F family members, but all appeared active
in suppressing E2F function. This raises the question as to how
cyclin E is ever switched on, in order to trigger CDK2/Cyclin
E-mediated RB-hyperphosphorylation, leading Narasimha et al.
(2014) to invoke the existence of some other mechanism for
inducing cyclin E expression not involving E2F.
The contrary conclusions of Chung et al. (2019) that
CDK4,6/D alone is sufficient for RB hyperphosphorylation
depend heavily on the use of palbociclib to inhibit CDK4,6/D
activity. However, recent studies of the crystal structure of
trimeric complexes between CDK4, cyclin D1 and either p21 or
p27 indicate that the action of palbociclib is much more nuanced
than previously appreciated (Guiley et al., 2019; Sherr, 2019).
Although p21 and p27 are strong inhibitors of CDK1,2/E,A
activity, their action on CDK4,6/D has been less clear-cut. In
contrast to other CDK-cyclin complexes, CDK4,6 associates
poorly with cyclin D, requiring the assistance of assembly factors,
which include Hsp90, Cdc37 and p21 or p27. Indeed, mouse
embryo fibroblasts lacking both p21 and p27 are unable to
form active CDK4-Cyclin D complexes (Cheng et al., 1999). The
structural studies of Guiley et al. showed how p21 and p27 are
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able to bring CDK4 and Cyclin D together, facilitating complex
formation and promoting conformational changes conducive
to enzymatic activity (Guiley et al., 2019). Nevertheless, the
p21-CDK4-Cyclin D1 trimer lacked kinase activity, making p21
an inhibitor, consistent with single-cell imaging data from Yang
et al. (2017). (This, of course, implies that p21 would need
to dissociate from the CDK4-cyclin D dimer after facilitating
assembly if it is to function as a promoter of activity.) As with
p21, the binding of p27 was also inhibitory until, that is, it
is phosphorylated on Tyr74 (a site lacking in p21). Assayed
in vitro, the resulting tyrosine-phosphorylated p27-CDK4-Cyclin
D1 trimer was an active kinase for RB and other CDK4/D targets
such as CDC6. Moreover, the tyrosine-phosphorylated trimer
had a lower Km for ATP than the CDK4-Cyclin D1 dimer
(0.4 mM vs. 1.5 mM), leading to the suggestion that tyrosine-
phosphorylated p27 is an allosteric activator of CDK4-Cyclin D1
(Guiley et al., 2019). However, since ATP levels inside cells are
typically in the mM range, the change in Km is unlikely to have
any major impact on physiological activity. More significant was
the finding that the kinase activity of the tyrosine-phosphorylated
trimer was not inhibited by palbociclib at all (Guiley et al., 2019),
in contrast to the strong inhibition of the CDK4-Cyclin D1 dimer.
Indeed, the binding of p27 and palbociclib to Cdk4 were found
to be mutually exclusive. Furthermore, in cells arrested in G1
after prolonged treatment with palbociclib (for 48 h), levels of
RB kinase activity in Cdk4 or cyclin D1 immunoprecipitates
remained unchanged. Instead, there was a reduction in the RB
kinase activity associated with CDK2 due, at least in part, to
increased levels of p21 in the immunoprecipitates. Guiley et al.
concluded that the cell cycle arrest induced by palbociclib was due
to an indirect inhibition of CDK2, possibly through disrupting
the p21-CDK4-Cyclin D1 trimer, leading to an accumulation of
CDK4 monomer bound to palbociclib, and freeing the otherwise
sequestered p21 to inhibit CDK2 (Guiley et al., 2019).
FIGURE 3 | A schematic illustrating a possible explanation of both RB-monophosphorylation and RB-hyperphosphorylation by CDK4,6/cyclin D. Growth factor
stimulation of quiescent cells leads the expression of Cyclin D, which complexes with CDK4,6 and p27. The trimer, when phosphorylated on Tyr74 of p27 (marked
YP) is a weak kinase for RB (resistant to palbociclib), enabling monophosphorylation of RB. (Whether tyrosine phosphorylation of p27 is restricted to the trimer or
applies equally to the monomer, is not known. The lack of p27 monomers marked with YP in the diagram should not be taken therefore to imply that phosphorylation
of the monomer does not occur.) As cyclin D expression continues, more and more of the trimer accumulates, eventually sequestering all the p27 monomers. From
then on, further production of cyclin D leads to fully active CDK4,6/cyclin D dimers (sensitive to palbociclib) that hyperphosphorylate Rb. The derepressed E2F then
induces expression of cyclin E which, together with CDK2, sustains Rb hyperphosphorylation thereafter.
Frontiers in Cell and Developmental Biology | www.frontiersin.org 8 July 2021 | Volume 9 | Article 698066
fcell-09-698066 July 19, 2021 Time: 19:34 # 9
Brooks Origins of Cell Cycle Variability
Although the tyrosine-phosphorylated p27-CDK4-Cyclin D1
trimer was said to be an active RB kinase, this depends on
how kinase activity is measured. Using a recombinant fragment
of RB consisting of amino acids 771–874, the trimer was just
as active as the CDK4-Cyclin D1 dimer. However, this RB
fragment lacks a C-terminal alpha helix (amino acids 892–912)
that provides an essential docking site required for efficient
binding to CDK4,6-Cyclin D (Topacio et al., 2019). Using a larger
RB fragment (amino acids 771–928) containing this docking site,
the tyrosine-phosphorylated p27-CDK4-Cyclin D1 trimer is a far
less active kinase than the CDK4-Cyclin D1 dimer, with a 13-
fold lower Vmax (Guiley et al., 2019). Thus, far from being an
activator, p27 is an inhibitor of kinase activity for RB-substrates
with an intact C-terminal tail. This could potentially explain
the monophosphorylation of RB (Figure 3). On mitogenic
stimulation of quiescent cells, the first cyclin D to be produced
will be complexed with both CDK4,6 and p27 (Figure 3). After
phosphorylation of p27 on Tyr74 (most likely by Src-like kinases,
themselves responsive to mitogenic stimulation – Chu et al.,
2007), the trimeric complex would gain sufficient kinase activity
to be able to start the phosphorylation of RB (Figure 3). However,
after adding the first phosphate, the association between RB
and the trimer could conceivably be weakened (perhaps due
to altered electrostatic charge), encouraging dissociation. Even
without such weakening, by not being able to hold on tightly to
the C-terminal docking helix due to blocking by p27 (Guiley et al.,
2019), the p27-CDK4,6-cyclin D1 trimer might dissociate from
RB before the addition of any further phosphates to it. If so, then
only after sufficient cyclin D has been produced to sequester all
the p27 in the cell, will CDK4,6/cyclin D dimer start to appear
with full activity toward RB to ensure its hyperphosphorylation
(Figure 3). (This built-in delay could be of value in enabling the
cell to grow in mass before reaching a point of commitment to
the next cell cycle.) Note that a possible argument against this
scenario – that RB monophosphorylation was reported to be
blocked by palbociclib (Narasimha et al., 2014) – can be dismissed
because the palbociclib appears to have been added at the time
of serum step-up, before the induction of cyclin D. As a result,
the palbociclib would have bound first to CDK4,6 monomer
(Guiley et al., 2019), preventing its subsequent association with
cyclin D and p27.
If these speculations are correct, then the RB
hyperphosphorylation seen in CDK/E,Aincreasing cells
immediately after mitosis could conceivably be due entirely
to palbociclib-sensitive CDK4,6/cyclin D dimers, even though
these may be a minor fraction of the total CDK4,6/cyclin D
in the cell (Guiley et al., 2019). Nevertheless, when nearing
the end of G1, cells have elevated levels of CDK2/E activity,
just below those needed for entry into S phase. On inhibiting
fully active CDK4,6/cyclin D dimers with palbociclib, there
should be sufficient CDK2/E activity remaining to sustain
RB hyperphosphorylation in the absence of CDK4,6/cyclin D
activity. Instead, Chung et al. (2019) found complete reversal
of RB hyperphosphorylation after just 15 min treatment with
palbociclib. This implies that the CDK2/E present has no activity
toward RB, which is difficult to understand. The most likely
explanation would seem to be that palbociclib causes rapid
dissociation of CDK4-Cyclin D1 trimer complexes with p27 or
p21, freeing the sequestered p21/p27 to inhibit the CDK2/E,
i.e., an indirect inhibition of CDK2 activity by palbociclib, as
suggested by Guiley et al. (2019). Consistent with this, the
activity of CDK2/E is seen to start falling immediately after
the addition of palbociclib (Chung et al., 2019). Thus, the
provocative suggestion of Chung et al. (2019) that Cyclin E
plays no role in RB hyperphosphorylation until after the G1/S
transition remains to be established, by ruling out any indirect
inhibition of CDK2/E by palbociclib. This could perhaps be done
by repeating the experiments with cells deficient for both p21
and p27. In this case, palbociclib should be unable to reverse
RB hyperphosphorylation and block entry into S phase after
the point of mitogen independence (passage of the Restriction
Point), as there would be no sequestered p21 or p27 to relocate
to and inhibit CDK2/E. However, cells lacking both p21 and p27
may be compromised in their assembly of active CKD4,6/cyclin
D complexes (Cheng et al., 1999), which would complicate
the experiments.
APC/CCDH1 INACTIVATION
In continuous cycling cells or in cells stimulated from quiescence,
there comes a point in G1 when CDK2/E,A activity starts to
rise inexorably and monotonically, indicating the start of the
next cycle (Figure 2A). Activity reaches a peak at mitosis, after
which it declines rapidly toward a baseline. As the level rises from
baseline to peak, a threshold is reached when the cell becomes
irreversibly committed to entry into S phase (Spencer et al.,
2013; Barr et al., 2016; Schwarz et al., 2018; Chung et al., 2019).
A similar requirement to achieve a threshold level of CDK activity
for entry into S phase is also seen in Fission yeast (Coudreuse and
Nurse, 2010), suggesting that this is a universal requirement. An
important question that follows on from this is how a gradually
increasing level of CDK activity is translated into an abrupt, all-
or-none commitment to enter S phase. Recent live-cell imaging
studies suggest that inactivation of the Anaphase Promoting
Complex or Cyclosome (APC/C), a multimeric ubiquitin E3-
ligase, may be key to this.
The activity of APC/C depends on two substrate-recognition
adaptor proteins, CDC20 and CDH1 (reviewed, Peters, 2006).
Anaphase is brought about by APC/C complexed with CDC20.
On exit from mitosis, CDC20 dissociates from APC/C and is
replaced by CDH1, maintaining APC/C activity throughout G1.
This prevents the accumulation of many proteins needed for S
phase (see later). Switching off APC/CCDH1 is therefore essential
for entry into S phase and in keeping with this, CDH1 knockdown
accelerates the G1/S transition (Sigl et al., 2009; Yuan et al., 2014).
By using a fluorescent reporter construct consisting of
a fragment of geminin (a well-established APC/C target)
conjugated to mCherry (Sakaue-Sawano et al., 2008), it has been
possible to follow the activity of APC/CCDH1 in living cells, in real
time (Cappell et al., 2016). Remarkably, APC/CCDH1 activity was
found to disappear extremely abruptly in a switch-like manner (as
illustrated in Figure 2B), over a span of about an hour (Cappell
et al., 2016). The inactivation of APC/CCDH1 occurred at different
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times in different cells (Figure 2B), but was always just before
the onset of S phase. For cells stimulated from quiescence, this
was several hours after RB hyperphosphorylation and passage
of the Restriction Point (apparent mitogen independence). The
inactivation of APC/CCDH1 required CDK2/E activity and was
blocked by a low dose of a CDK1,2 inhibitor or by knockdown
of cyclin E with siRNA (though not cyclin A). However, once
inactivated (“off”), APC/CCDH1 could not be switched on again
with the same low dose of CDK1,2 inhibitor (Cappell et al.,
2016, 2018), consistent with inactivation being an irreversible
transition. For the cells in which CDK/E,A activity does not rise
immediately after M (the CDK/E,Alow population), APC/CCDH1
activity remains “on” for as long as CDK/E,A activity continues
to be low. However, once CDK/E,A activity starts to rise,
APC/CCDH1 inactivation typically follows 3–5 h later, suggesting
a requirement to reach a threshold level of activity.
A schematic illustrating the major interacting networks
surrounding APC/CCDH1 and its connections to the RB-E2F
switch and the onset of DNA synthesis, is shown in Figure 4.
The abruptness of the fall in APC/CCDH1 activity, once it starts
(Figure 2B), is unaffected by a pan-cullin inhibitor (Cappell et al.,
2016). This indicates that the sudden, sharp fall in APC/CCDH1
activity is not dependent on the SCF (Skp1/CUL1/Fbox protein)
family of cullin E3 ubiquitin ligases that become active from
late G1 to the end of G2, following APC/CCDH1 inactivation
(Figure 4). In keeping with this, knockdown of the SCF-substrate
adaptor Cyclin F, with siRNA, also failed to alter the kinetics
of APC/CCDH1 inactivation (Cappell et al., 2018), even though
SCFcyclinF is able to target CDH1 for destruction, and vice
versa (Choudhury et al., 2016). Thus, the potential double-
negative feedback loop between APC/CCDH1 and SCFcyclinF
(Choudhury et al., 2016) – see Figure 4 – does not appear
to be involved in controlling the abruptness of APC/CCDH1
inactivation (Cappell et al., 2018), though it could contribute to
its timing or the maintenance of inactivation once it has occurred.
Likewise, knockdown of another SCF-substrate adaptor, SKP2,
with siRNA, also fails to alter the kinetics of APC/CCDH1
inactivation (Cappell et al., 2018). This shows that the abruptness
of inactivation is not the result of increased CDK2/E activity
following SCFSKP2-mediated elimination of p21 or p27 from
inhibitory complexes with CDK2/E (Barr et al., 2016, 2017),
though again some contribution to timing or maintenance of the
APC/CCDH1 switch cannot be ruled out (Figure 4). In contrast,
siRNA-mediated knockdown of the APC/CCDH1 inhibitor EMI1
does slow the rate of APC/CCDH1 inactivation (Cappell et al.,
2016, 2018). Moreover, although inactivation of APC/CCDH1 still
occurs after elimination of EMI1, after a delay during which
CDK/E activity continues to rise, it is no longer irreversible to
treatment with a low dose of CDK1,2 inhibitor. In addition,
overexpression of EMI1 brought forward the abrupt inactivation
of APC/CCDH1 (Cappell et al., 2016). Thus EMI1 controls the
timing, abruptness and irreversibility of APC/CCDH1 suggesting
that it plays a key part in the bistability of the switch (Figure 4).
This bistability arises because EMI1 is both a substrate of
APC/CCDH1 at low concentrations, and an inhibitor of it at
high concentrations, creating a double-negative feedback loop
(Cappell et al., 2018).
Expression of EMI1 is induced by E2F (Hsu et al., 2002) after
RB hyperphosphorylation and the RB-E2F switch (Figure 4).
Initially, the newly made EMI1 is targeted for destruction
by APC/CCDH1, keeping its concentration low. However, as
CDK2/E activity rises, it phosphorylates and gradually inhibits
APC/CCDH1 allowing EMI1 to evade destruction and start
accumulating. On reaching a threshold, EMI1 switches from
being a substrate to being an inhibitor, further suppressing
APC/CCDH1. This favors yet further accumulation of EMI1
culminating in complete inactivation of APC/CCDH1. Thus,
the threshold for this switch is governed by both the level
of CDK2/E activity and the concentration of EMI1. Without
EMI1, inactivation of APC/CCDH1 can still occur but requires
a much higher CDK2/E activity, thereby delaying the switch.
Conversely, upregulation of EMI1 brings forward the switch
(Cappell et al., 2016, 2018).
APC/CCDH1 INACTIVATION MARKS THE
POINT OF NO RETURN IN THE CELL
CYCLE
Passage of the Restriction Point – usually equated with
flipping of the RB/E2F switch and the acquisition of mitogen
independence – is widely considered to be the critical point
of no return in the cell cycle, when cells become irreversibly
committed to the next cycle. However, the fact that entry into
S phase can be blocked by palbociclib almost right up to
the G1/S transition, with reversal of RB hyperphosphorylation,
calls this into question (Chung et al., 2019). Regardless of the
precise mechanism of action of palbociclib (as discussed earlier),
this indicates a continuing role for CDK4,6/D (either direct,
through RB phosphorylation, or indirect, through sequestering
p27 or p21 away from CDK2/E) almost right up to the start
of DNA synthesis. In contrast, once APC/CCDH1 is inactivated,
palbociclib is no longer able to arrest the cycle, consistent with
inactivation being an irreversible transition.
In addition to treatment with palbociclib, cellular stress
has also been reported to reverse passage of the Restriction
Point, returning cells to quiescence (Cappell et al., 2016).
When “early” G1 cells were exposed to a low dose of
neocarzinostatin (NCS) to induce DNA damage, at a time
when RB was already hyperphosphorylated and CDK/E,A
activity had started to rise, some of the cells transiently
reverted to having unphosphorylated/monophosphorylated RB,
and the rise in CDK/E,A activity was delayed (for around
8 h). In addition, APC/CCDH1 activity remained “on.” Similar
results were seen after hypertonic treatment or exposure to
hydrogen peroxide. If, after treatment with NCS, the cells
were deprived of mitogens, most of those that reverted to
unphosphorylated/monophosphorylated RB remained in this
state, maintaining low CDK/E,A activity, suggesting a return to
quiescence and the regaining of mitogen dependence. Consistent
with this, when mitogens were restored, the cells resumed
cycling, with CDK/E,A activity rising once more, followed by
APC/CCDH1 inactivation. However, the lag between mitogen
restoration and the rise in CDK/E,A activity or APC/CCDH1
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FIGURE 4 | A schematic integrating the RB-E2F switch (left) with the APC/CCDH1 switch (center-right). For details, see text.
loss was very short (less than 4 h, though rather imprecise) –
much less than the normal pre-replicative lag (of around 12 h).
Evidently, stress exposure had not returned the cells to a normal
quiescent (G0) state. Nevertheless, the same stress exposures
given after APC/CCDH1 had switched off were without effect,
and did not lead to APC/CCDH1 reactivation. This reinforces the
conclusion that once APC/CCDH1 has been inactivated, the cell
passes into a state from which it cannot easily return.
One of the few interventions known to allow reactivation of
APC/CCDH1 once it is switched off involves the knockdown of
EMI1 (Barr et al., 2016; Cappell et al., 2016, 2018). However,
such reactivation, after entry into S phase, leads to re-replication
of DNA (Barr et al., 2016), so is not without deleterious
consequences for the cell.
The only other intervention known to induce APC/CCDH1
reactivation, after it has been switched off, is DNA damage
(Wiebusch and Hagemeier, 2010; Segeren et al., 2020). On the
face of it, this might seem to contradict the findings of Cappell
et al. (2016), who found no such reactivation, as indicated above.
However, the time span of these studies is quite different. Starting
with cells that had just undergone APC/CCDH1 inactivation,
Cappell et al. (2016) found no reactivation, following a short
pulse with a low dose of NCS, over the next 8 h. In the
studies by Wiebusch and Hagemeier (2010) and Segeren et al.
(2020), somewhat higher levels of DNA damaging agents also
produced little change in APC/CCDH1 activity over the first
6 h. Only after this did APC/CCDH1 levels start to rise,
reaching a maximum roughly 12 h later. This reactivation of
APC/CCDH1 was accompanied by the loss of EMI1, through
degradation and the suppression of transcription (Wiebusch
and Hagemeier, 2010). Importantly, experimental upregulation
of EMI1 in S phase through knock-out of the E2F repressors
E2F7/8, or overexpression of an activator E2F (E2F3), prevented
the reactivation of APC/CCDH1 (Segeren et al., 2020) after
DNA damage, again underscoring the importance of EMI1
in maintaining the APC/CCDH1 off-state (c.f. Figure 4). The
pathway through which DNA damage brings about APC/CCDH1
reactivation involves the induction of p53, which in turn
acts partly through transactivation of E2F7 (and suppression
of EMI1), but in particular through upregulation of p21
(Wiebusch and Hagemeier, 2010; Segeren et al., 2020). Exactly
how p21 contributes to the reactivation of APC/CCDH1 was
not established, but it is likely to be through inhibition of
CDK2/cyclin E (c.f. Figure 4). Previously, Cappell et al. (2018)
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had reported no reactivation of APC/CCDH1 once it had switched
off, using the maximum tolerated dose of a small molecule
CDK1,2 inhibitor. However, the very high levels of p21 seen
after DNA damage (Wiebusch and Hagemeier, 2010; Segeren
et al., 2020) may have achieved a more-complete inhibition of
CDK2/cyclin E, sufficient to reverse the switch (Cappell et al.,
2018). As with EMI1 knock-down above (Barr et al., 2016),
the consequences of this premature reactivation of APC/CCDH1,
after DNA damage, are not benign, and include cell senescence
(Wiebusch and Hagemeier, 2010) or re-replication (Segeren et al.,
2020). Clearly, inappropriate reversal of the APC/CCDH1 switch is
not something easily tolerated.
APC/CCDH1 INACTIVATION
REPRESENTS A CHANGE OF STATE IN
THE CELL CYCLE
Following the sudden inactivation of APC/CCDH1, ubiquitin-
mediated proteolysis in the cell cycle shifts abruptly from being
APC/CCDH1-dependent to primarily SCF-dependent, marking a
fundamental change of state (Figure 5). Prior to this transition,
CDH1 is stable, targeting APC/C to the destruction of its own
inhibitor, EMI1 (as already discussed). Also targeted are Cyclin F
(Choudhury et al., 2016) and SKP2 (Bashir et al., 2004; Wei et al.,
2004), substrate adaptors for SCF, keeping them “switched off.”
After the transition switching off APC/CCDH1, EMI1 is stabilized
and maintains the suppression of APC/CCDH1. Since cyclin F is
no longer eliminated, SCFcyclinF also now accumulates, targeting
CDH1 for proteolysis and further reinforcing the irreversibility
of APC/CCDH1 inactivation (Choudhury et al., 2016). Similarly,
stabilization of SKP2 after APC/CCDH1 inactivation leads to the
formation of SCFSKP2, which targets any p21 or p27 present
for proteolysis, after they have been phosphorylated by CDK2/E
(Lu and Hunter, 2010). The active CDK2/E released would in
turn further assist in maintaining the suppression of APC/CCDH1
(Figure 4). Indeed, since phosphorylation of SKP2 on Ser64 by
CDK2/E can prevent its interaction with APC/CCDH1 (Rodier
et al., 2008), stabilizing it, it is possible that some SCFSKP2 may
appear even before full APC/CCDH1 inactivation, contributing to
the timing of the switch, through p21 or p27 elimination and
CDK2/E activation (Barr et al., 2016, 2017; Heldt et al., 2018).
Prior to the APC/CCDH1 “off” transition, factors required for
DNA synthesis are actively destroyed. These include Cyclin A,
which maintains CDK2 activity after the decline of Cyclin E
following the start of S phase, and DBF4, an activator of CDC7
kinase, also known as DDK (DBF4-dependent kinase) (Figure 4).
Conversely, the licensing of replication origins is favored.
Licensing involves recruiting the MCM helicase to origins of
replication, mediated by the licensing factors CDT1 and CDC6.
These in turn bind to the hexameric Origin Recognition Complex
(ORC1-6) assembled at potential initiation sites along the DNA
(Blow and Dutta, 2005; Fragkos et al., 2015). Expression of both
CDT1 and CDC6 is induced by E2F (Figure 4). However, CDC6
is initially targeted for destruction by APC/CCDH1 until it gets
phosphorylated by CDK2/cyclin E, which blocks recognition by
CDH1, stabilizing it (Mailand and Diffley, 2005; Figure 4). This
opens up a window for origin licensing between the appearance
of CDK2/cyclin E and the inactivation of APC/CCDH1.
After the inactivation of APC/CCDH1, DBF4 and cyclin A are
no longer targeted for proteolysis and are able to accumulate,
facilitating, along with CDK2 and cyclin E, the initiation of
DNA synthesis (Fragkos et al., 2015). At the same time, CDC6
and CDT1 become targeted for destruction by SCFcyclinF and
SCFSKP2 respectively (Figures 4, 5), terminating the capacity for
further origin licensing (or re-licensing). In addition, geminin
(an inhibitor of CDT1 through direct binding), is now able to
accumulate (Figures 4, 5), reinforcing the suppression of origin
licensing. Thus, after APC/CCDH1 inactivation, cells pass from
a state where origin licensing is possible but DNA replication is
not, to one where the initiation of DNA synthesis can occur but
relicensing cannot.
THE G1/S TRANSITION AND THE
INITIATION OF DNA SYNTHESIS
Entry into S phase, marked by the initiation of DNA synthesis,
occurs with inevitability and very quickly (in an hour or so),
after APC/CCDH1 is switched off (Cappell et al., 2016). When
DNA synthesis begins in a given cell, it does so simultaneously
at dozens of separate replication foci scattered throughout the
nucleus (Newport, 1996). This would seem to suggest a sudden,
global change of state acting throughout the nucleus to trigger
the onset of DNA synthesis at multiple origins, but what this
might be remains unclear. The firing of replication origins
requires both CDK activity (driven by either cyclin E or cyclin
A) and DDK activity (driven by DBF4) (Fragkos et al., 2015).
As discussed earlier, CDK/E,A activity increases rather gradually
during G1 and it is difficult to see how just attaining a threshold
could have the switch-like precision to trigger the synchronous
firing of numerous, dispersed replication foci, each consisting of
multiple replication origins. The requirement for DDK activity
explains why the initiation of DNA synthesis cannot take place
before APC/CCDH1 is switched off since it is only after this that
DBF4 is able to accumulate (Figure 5). However, the gradual
accumulation of DBF4, after the switch, again makes it difficult
to explain simultaneous initiation at multiple foci, at the start of
S phase. The fact that it requires both CDK and DDK activity
adds an element of cooperativity, but synchronous origin firing
remains difficult to understand in the absence of a switch-like
mechanism acting throughout the nucleus.
Although the number of licensed origins declines with time
during quiescence, in recently quiescent cells enough origins
remain licensed for the isolated (intact) nuclei to enter DNA
synthesis when transferred into cytoplasmic S phase extracts from
Xenopus eggs (Sun et al., 2000). Nevertheless, individual nuclei
apparently begin DNA synthesis at different times, despite being
present in the same S phase cytoplasm (Hola et al., 1994, 1996).
The asynchrony is not correlated with differences in nuclear
transport (Sun et al., 2001) and is therefore unlikely to be caused
by differences between nuclei in the time taken to accumulate
replication factors to a critical threshold. Instead, individual
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FIGURE 5 | The change of state resulting from APC/CCDH1 inactivation. Prior to this transition, the cell is in a state where proteolysis targeted by APC/CCDH1
predominates, leading to the elimination of EMI1, its own inhibitor, together with substrate adaptors for the SCF-ubiquitin ligase, and components needed for DNA
synthesis such as DBF4 and cyclin A. Factors required for replication origin licensing (CDC6 and CDT1) are stable whereas geminin – an inhibitor of CDT1 and hence
licensing – is destroyed. Following the switch, SCF-mediated-proteolysis is promoted by the stabilization of its substrate adaptors (such as SKP2 and cyclin F).
Origin firing becomes possible on accumulation of DBF4, acting together with CDK2 activity promoted first by cyclin E, then cyclin A, with activity further enhanced
by p27 and/or p21 elimination. Origin relicensing is prevented in part by SCF-targeted degradation of the CDC6 and CDT1 licensing factors together with CDT1
suppression through geminin accumulation. Thus, at the point of APCCDH1 inactivation, the cell passes from a state where origin licensing is possible but origin-firing
is prevented, to one where origin-firing becomes possible but relicensing is suppressed. The change of state, once it occurs, is irreversible due to EMI1 stabilization
and SCF-mediated elimination of CDH1.
quiescent nuclei must vary in their sensitivity to the replication-
inducing factors in Xenopus egg extracts. Remarkably, when
permeabilized binucleate cells are added to such extracts, both
nuclei of a pair show identical levels of DNA synthesis suggesting
synchrony in the timing of initiation, even though different pairs
of nuclei start DNA synthesis at different times (Hola et al.,
1996). Clearly, whatever determines the sensitivity of nuclei to
the inducers of DNA synthesis, it is a property shared by nuclei
formed in a common cytoplasm. (The binucleate cells were
generated by blocking cytokinesis with cytochalasin B, prior to
serum withdrawal to render them quiescent.) One possibility
that might explain this is the degree of chromatin condensation.
It is well known that different sets of replication origins fire
at different (and reproducible) times throughout S phase, with
heterochromatin (the most-condensed) replicating late (Fragkos
et al., 2015). Thus the differences between pairs of binucleates in
the time taken to start replicating may simply reflect the degree
of chromatin compaction at the time of permeabilization and
exposure to egg cytoplasm. That such chromatin differences exist
may be inferred from the studies of Yen and Pardee (1979),
who noted for quiescent 3T3 cells that nuclear volume varied
over a twofold range, despite DNA content being the same.
Moreover, the cells with the largest nuclei (and, presumably,
the most dispersed chromatin) were the first to start DNA
synthesis after serum stimulation. Thus, the first nuclei to start
DNA synthesis in egg extracts may simply be the ones with the
most-open chromatin. This in turn offers a plausible explanation
for the apparently simultaneous firing at multiple replication
foci scattered throughout the nucleus on entry into S phase.
These clusters of early firing origins are simply those in the
most open chromatin, able to respond to the lowest level of
replication-inducers as the cell first enters S phase, with origins
in more-compacted chromatin firing later as the concentration
of inducers in the nucleus rises, or the chromatin becomes
decondensed. The apparently synchronous firing of multiple foci
at the start of S phase may therefore be a reflection merely of
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similar origin-sensitivity (accessibility), rather than the response
to some global change of state extending throughout the nucleus
at the time of the G1/S transition, downstream of APC/CCDH1
inactivation. If so, then the interval between the APC/CCDH1
“off” transition and the start of DNA synthesis, though short,
would be expected to show some variation, inversely with nuclear
volume (a surrogate for chromatin compaction). However, any
such variance would be expected to be shared by sister cells, as
with the nuclei of binucleates.
BISTABLE SWITCHES AND RANDOM
TRANSITIONS IN THE CELL CYCLE
For cells stimulated to re-enter the cell cycle from quiescence,
the APC/CCDH1 inactivation switch is triggered by the rise in
CDK2/E activity that follows on from passage of the Restriction
Point, which in turn is triggered by RB-hyperphosphorylation
and the RB-E2F switch. It seems reasonable to ask whether
these two bistable switches might correspond to the two random
transitions postulated in the revised Transition Probability model
(Brooks et al., 1980).
The original version of the Transition Probability model
(Smith and Martin, 1973) proposed that cell cycle commitment
involved a single random transition in G1, the probability of
which varied with conditions. The transition, if it existed, divided
the cycle into two parts, an A state in G1 in which cells “waited”
for commitment to occur, and a deterministic B phase (the rest
of the cell cycle, including S, G2, M and part of G1) which cells
were obliged to complete, once started. The model accounted for
the connection between cell cycle variability and the regulation of
proliferation, for the exponential tail of the distribution of cycle
times and for various other aspects of cell cycle kinetics including
the invariable difficulty of synchronizing cells from one cycle to
the next. Nevertheless, at first sight the model seemed unlikely
since it was known that the cycle times of sister cells were highly
correlated, with correlation coefficients typically of the order of
0.5. If each cycle were initiated purely at random then there is no
reason why sister cell cycle times should be any more alike than
random pairs. Nevertheless, sister cells rarely divide at exactly the
same time and it transpired that the distribution of differences
between sister cell cycle times (the so-called β-curve) was a near
perfect exponential, indicating that all of the differences could
be accounted for solely in terms of a single random transition
(Minor and Smith, 1974; Shields, 1977, 1978; Shields and Smith,
1977). Cycle times as a whole, however, are more variable than
predicted by a single random transition. It follows that B phase
must vary in general, while being identical in sister cells.
The Two Transition extension of the Smith and Martin model
(Brooks et al., 1980; Brooks, 1981) arose from attempts to account
for the lag preceding entry into S phase following the restoration
of serum to serum-starved, quiescent cells. After the lag, cells
entered S phase with what appeared to be first order kinetics,
as discussed earlier, consistent with the Smith and Martin model
(Brooks, 1975, 1976). The random transition – if there was one –
had to be placed toward the end of the lag, since this was always
much longer than the minimum G1 of continuously cycling cells.
Consistent with this, the rate of entry into S phase declines
quite quickly after removing the serum once more (Brooks,
1976). To explain the lag, and its independence on the level
of stimulation, it was proposed that some lengthy process or
processes, taking up most of the lag (and therefore called L) had to
be completed before entry into S phase became possible. Process L
was considered to start stochastically (the so-called Q transition),
with a probability dependent on the level of stimulation. On
completion of L, the cell was competent to undergo commitment
to enter S phase, this corresponding to the Smith and Martin
transition. At the same time, the “clock” was reset so that L could
begin again (stochastically) in readiness for the next cell cycle.
However, since L was longer than S+ G2, it would be completed
after mitosis in G1 of the daughter cells. Accordingly, sister cells
would reach the point of commitment to S phase (the Smith and
Martin transition) at the same time, thereby explaining both the
sibling correlation and the exponential distribution of differences
between sisters.
The two transition version of the Transition Probability
model turned out to provide a remarkably good quantitative
description of cell cycle variability in continuously cycling cells
using just two parameters (the two transition probabilities),
both of which were fixed in advance by the observed cell cycle
statistics (standard deviation of cycle times, the mean or standard
deviation of differences between sibling cycle times, and the
sibling correlation), rather than curve-fitting (Brooks et al., 1980,
1983; Brooks, 1981, 1985). But, the nature of process L was
never identified; early hopes that it might correspond to the
biogenesis of mitotic centers (centrosomes) were not fulfilled
(Brooks and Richmond, 1983; Alvey, 1985). In addition, many
alternative models of cell cycle variability have been proposed
and kinetics alone are insufficient to distinguish between them
(Castor, 1980; Cooper, 1982; Yao, 2014; Arata and Takagi, 2019).
Also lacking at the time was any plausible biological basis
for the random transitions. Accordingly, transition probability
models (and other kinetic models of the cell cycle) largely
fell from view in favor of efforts to understand the molecular
basis of cell cycle control. However, developments in systems
biology have shown how interacting networks of continuous
processes containing positive or double-negative feedback loops
can generate bistability and ultrasensitivity, switching abruptly
and irreversibly from one steady state to another with minimal
perturbation (Thron, 1997; Aguda and Tang, 1999; Qu et al., 2003;
Novák and Tyson, 2004; Yao et al., 2008; Stallaert et al., 2019).
Such behavior could well provide an explanation for probabilistic
transitions in terms of the now established molecular players in
cell cycle control. A reconsideration of the two-transition model
therefore seems timely.
Early studies indicated that the A state transition of the
original Smith and Martin transition probability model – if it
existed – must be located very close (within an hour or so) to
the start of S phase (Brooks, 1977). A good case can be made
that this transition corresponds to the abrupt and irreversible
inactivation of APC/CCDH1. This event occurs at very different
times in different cells (Cappell et al., 2016, 2018; Chung et al.,
2019). It is triggered by the rise in CDK/E,A activity, the onset
of which also shows a great deal of variability in timing between
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individual cells (Spencer et al., 2013; Overton et al., 2014; Arora
et al., 2017; Barr et al., 2017; Moser et al., 2018). In cycling
cells, the timing of the rise in CDK/E,A activity depends on
the level of CDK4,6/D activity immediately after mitosis, which
in turn depends on mitogenic signaling or replication stress in
the mother cell (Spencer et al., 2013; Arora et al., 2017; Barr
et al., 2017; Yang et al., 2017; Chung et al., 2019; Min et al.,
2020). This means that sister cells are in a similar state at birth
and likely to reach the point when CDK/E,A activity starts to
rise at the same time, accounting for much (possibly all) of the
correlation between sister cell cycle times. However, subsequent
activation of the APC/CCDH1 switch is likely to occur at different
times in sister cells due to stochastic variation. It seems possible
that such differences in APC/CCDH1 inactivation account for
the majority of variation between siblings in the timing of S
phase entry, and subsequently mitosis. For continuously cycling
cells, the differences between sister cell cycle times are an
almost perfect exponential distribution (the so-called β-curve),
providing the most compelling evidence for the Smith & Martin
A state transition, as already discussed). It would therefore be of
considerable interest to know whether differences in the timing
of APC/CCDH1 inactivation in siblings are also exponentially
distributed and identical to the differences in sister cell cycle times
(the β-curve).
Although evidence for one random transition in the cell
cycle remains good (β-curves), that for a second transition was
always much less secure (Brooks, 1985). When the differences in
sibling cycle times are subtracted, the left-over variation in cycle
times within the population is well described by an exponential
distribution (Brooks et al., 1980). However, it is likely that almost
any other skewed distribution could fit just as well (Brooks,
1985). For cells re-entering the cycle from quiescence, it is clear
that there is a great deal of population heterogeneity in the
level of mitogenic stimulus required, with some cells much more
sensitive than others. Transition probability models provide no
insight into this heterogeneity. However, stochastic activation
of a bistable RB-E2F switch, coupled with a variable switching
threshold within the population (Kwon et al., 2017) due to known
heterogeneity in the level of CDK-inhibitors such as p27 (Hitomi
et al., 2006), is an attractive possibility.
Although the RB-E2F switch is widely accepted as the basis
of the Restriction Point, as already discussed, in many types of
continuously cycling cells, the majority are post-Restriction Point
from birth, in so far as they continue on to S phase without further
need of mitogenic stimulation (Spencer et al., 2013; Schwarz et al.,
2018). The apparent lack of requirement for an RB-E2F switch
can be explained if the level of CDK4,6/D activity is sufficiently
high to stimulate enough active E2F (i.e., above the threshold
required) to generate self-sustaining levels of cyclin E, from the
start of G1. The level of CDK4,6/D activity after mitosis will
depend on the extent of p21 and/or p27 expression, together with
the amount of cyclin D protein inherited from the mother cell
(Min et al., 2020). The levels of p21, p27 and cyclin D at the start
of G1 clearly vary from cell to cell, but will be inherited more or
less equally by sister cells, accounting for the sibling correlation.
However, there is no obvious role for the RB-E2F bistable switch,
or any other probabilistic transition in the mother cell cycle,
in explaining the post-Restriction Point state of daughter cells
from birth. Evidently, the RB-E2F switch is not an obligatory
feature of each and every cell cycle but a special case applicable
to cells re-entering the cycle from quiescence, or to cells born
with a level of CDK4,6/D activity below the threshold required
to achieve self-sustaining levels of cyclin E without mitogens (the
CDK/E,Alow cohort).
In conclusion, evidence for one random transition in the
cell cycle (the Smith and Martin “A” transition, located very
close to the start of S phase, continues to be compelling, and it
seems very plausible that it could correspond to the APC/CCDH1
inactivation switch. For continuously cycling cells, the existence
of a second random transition (the “Q” transition of the modified
model; Brooks et al., 1980), no longer seems likely, despite the
excellent quantitative predictions of the model. For quiescent
cells responding to mitogens, a good case can be made that the
RB/E2F switch is the basis of the Restriction Point. Nevertheless,
as discussed in an earlier section, stochastic noise in switching
seems to be a less important contributor to variability than factors
leading to differences in the threshold for switching between cells
(Kwon et al., 2017), in accounting for the variation in growth
factor sensitivity within a population.
OTHER SOURCES OF VARIATION IN THE
CELL CYCLE
If there is no probabilistic transition in the mother cell
determining levels of p21, p27, and cyclin D at the start of
G1 in daughter cells, then understanding the reasons why these
vary between cells becomes important. It is already established
that p21 levels reflect replication stress or unrepaired DNA
damage in the mother cell, indicating a purely deterministic
contribution to cell cycle variability (Arora et al., 2017; Barr et al.,
2017; Yang et al., 2017). Factors regulating p27 expression are
less well understood, other than that levels are generally low
in rapidly cycling cells and rise when cells become quiescent
(Coats et al., 1996; Hitomi et al., 2006). However, in contrast
to non-transformed cells, rapidly cycling HeLa cells, which lack
functioning RB-family proteins, have high levels of p27 in G1
(Barr et al., 2016), perhaps substituting for the lack of an
intact RB-E2F network. Further studies of the factors generating
variability in p27 expression at the level of single cells, and the
contribution of such variability to cell cycle timing, would seem
to be a priority.
As for variability in the amount of cyclin D inherited by
daughter cells, this is determined by differences in translational
capacity at the end of G2 in mother cells (Min et al., 2020).
Translational capacity is a reflection of the number of ribosomes
per cell, at least in part, and is therefore an indicator of cell size.
The bigger the cell, the greater will be the total amount of cyclin
D made in any moment in time, even though the translation rate
per ribosome is likely to be similar between cells of different size.
Since cyclin D is a nuclear protein, it will be concentrated in
the nucleus. Bigger mother cells would therefore be expected to
achieve a higher nuclear concentration of cyclin D than small
cells, a difference that would be passed on to daughter cells.
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In turn, the higher nuclear levels of cyclin D in large daughters
would accelerate their transit through G1, compared to small
daughters. Cyclin D levels may therefore provide a link between
translational capacity – and hence cell size – and cell cycle timing,
potentially explaining (for mammalian cells) the widely observed
inverse relationship between cell size and cell cycle time (Prescott,
1956; Fantes, 1977; Johnston et al., 1977; Miyata et al., 1978;
Shields et al., 1978). A similar role in linking translation rate to
the speed of transit through G1 has also been proposed for Cln3
(a functional homolog of cyclin D) in budding yeast (Polymenis
and Schmidt, 1997; Litsios et al., 2019).
If the variation in cyclin D abundance at mitosis is due
primarily to variation in cell size, then the faster transit of large
daughters through G1 (due to high cyclin D), compared to small
daughters, would narrow the dispersion of size by the time of
the next mitosis. However, stochastic variation in the timing of
the APC/CCDH1 inactivation switch, would generate renewed
variation in cell size at division by affecting cycle length. These
two conflicting processes – one decreasing size variance and the
other increasing it – may help to explain how distributions of
cell size remain stable over time under steady state conditions.
Of course, many other factors are involved in the regulation
of cell size but further consideration of this important topic is
beyond the scope of this article. Instead, the reader is referred to
Zatulovskiy and Skotheim (2020) for an excellent recent review.
CONCLUDING REMARKS
As reviewed here, the recent technical innovations in live-cell
imaging have revolutionized the study of cell cycle regulation
and have brought renewed attention to the existence of cell
cycle variability. Ostensibly identical cells clearly undergo critical
transitions at different ages and with the focus on individual
cells, this variability becomes difficult to ignore. The parallel
developments in systems biology in understanding the role of
positive-feedback loops in generating molecular switches have
also provided invaluable insight into how cell cycle transitions
might be controlled (Thron, 1997; Aguda and Tang, 1999; Qu
et al., 2003; Novák and Tyson, 2004; Yao et al., 2008; Stallaert et al.,
2019). One such bistable switch – APC/CCDH1 inactivation – has
emerged as the most likely candidate for the point of no return
in the mammalian cell cycle (Cappell et al., 2018), and noisy
activation of the switch may well prove to be the basis of the
elusive Smith and Martin random transition. Should this not turn
out to be the case, then the origin of the exponential distribution
of differences between sister cell cycle times would return as an
important unanswered question.
For cell cycles as a whole, the variability is well-described
by two random transitions (Brooks et al., 1980). However, no
obvious candidate for the second transition has yet emerged.
Instead, this additional variability, shared by sister cells, is likely
to be a composite of several sources, of which cell size may
be one of the most important. Cell size, as a determinant of
translational capacity, influences the amount of cyclin D and
CDK4,6 activity inherited by daughter cells, and the timing of the
next cell cycle. In addition, nuclear size, again usually shared by
sister cells, seems likely to determine the time taken to respond to
the inducers of DNA synthesis present once the cell is committed
to enter S phase.
As for the Restriction Point – the moment when cell cycle
progress becomes independent of mitogenic stimulation – this
can no longer be regarded as an obligatory and irreversible
decision point in each and every cell cycle that all cells must
pass through. Rather, for many cell types, the majority of
rapidly cycling cells are already mitogen-independent from
birth. Such cells inherit a level of CDK4,6/D activity above the
threshold needed to generate sufficient cyclin E to maintain
RB hyperphosphorylation in the absence of further mitogenic
stimulation. However, cells born with a level of CDK4,6/D
activity below the threshold lose RB hyperphosphorylation and
return to a state of mitogen dependence for further progress
though the cell cycle. For these, and for long-term quiescent cells,
the Restriction Point concept remains valid. Indeed, stochastic
activation of the RB-E2F switch may contribute to some of the
variability in their subsequent re-entry into the cell cycle, though
a bigger contribution seems to come from heterogeneity in the
switching threshold, most likely due to differences between cells
in the levels of CDK inhibitors (p27, p21). As for the notion that
passage of the Restriction Point is strictly irreversible, this now
requires qualification. Although it is not reversible with normal,
physiological interventions (such as growth factor removal),
pharmacological blocking of CDK4,6/D and (probably) CDK2/E
activity (indirectly) leads to a loss of RB hyperphosphorylation
and a return to mitogen dependence (Cappell et al., 2016). This is
not possible after the APC/CCDH1 inactivation transition.
It is to be expected that further refinements of live-cell imaging
techniques will lead to ever fuller understanding of why cell
cycles are so variable. Nevertheless, it is worth emphasizing that
this will require great precision in determining the timing of
intracellular events. Classical cell biology approaches have led
to the conclusion that most cell cycle variability is in G1 and
that the duration of S + G2 is relatively constant (Sisken and
Morasca, 1965; Tobey, 1973; Shields et al., 1978; Brooks et al.,
1983; Zetterberg and Larsson, 1985). In contrast, recent live-
cell imaging studies using a fluorescent PCNA reporter have
concluded that G1, S, and G2 are all independently variable (Chao
et al., 2019). However, this rests on noise-free determination of
entry into and exit from S phase. These transitions are assessed
by changes in the granularity of PCNA fluorescence (nuclear
foci). In most cases, this is unambiguous, but with a few cells
it is difficult to say precisely when S phase begins and ends
(especially the former). Indeed, this is apparent in Figure 2E of
Chao et al. (2017) where a few cells in S phase have very few
PCNA foci. Such measurement uncertainty would increase the
apparent variance in phase length estimates, possibly explaining
the disparity with the older work. Measurement noise may also
be an issue in determining CDK/E,A activity. This involves
determining the ratio of nuclear to cytoplasmic levels of the DHB
reporter. As such, the estimate is affected by the variance in
both the nuclear and cytoplasmic measurements, which widens
the confidence intervals. Added to this, the measurements may
be affected by cell motility. As cells move, they round up and
flatten out periodically, to varying degrees. This is likely to affect
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the thickness of cytoplasm in the region of the ring around
the nucleus used for quantitating reporter fluorescence. This
could lead to variation in the fluorescence signal independent
of any change in CDK/E,A activity. Such noise could well
account for some of the differences in activity traces shown
by different cells. Quantitating, or better, eliminating any
such measurement noise is likely to become important in the
discrimination between models.
It has often been said that cell division is too important to
be left to chance yet variability seems to be embedded in the
very fabric of cell cycle control. There are very good reasons
why it should be. In free-living, single-cell organisms, cell cycle
entry is controlled by nutrient availability. When nutrients are
restored to starved cells, it would be undesirable for all of them to
commit immediately to cell cycle re-entry, in case the restoration
of nutrients is short-lived. If starvation conditions rapidly return,
this could compromise survival of cells already committed to cell
division. It is clearly advantageous for the timing of commitment
to vary between cells, particularly in response to suboptimal
conditions, where a graded response is needed in the population
such that some cells respond and others do not. In the case of
multicellular organisms, cell division is controlled less by nutrient
supply than by growth factor signaling in the context of tissue
homeostasis. After wounding, new cells are required to repair the
deficit, but it is important that not all cells in the tissue respond
to the stimulus, to avoid an overshoot. This is not just a matter
of having a localized stimulus in the proximity of the wound. In
partial hepatectomy, cell division resumes throughout the liver
remnant, not just at the cut edge, yet the response is proportional
to need (the extent of hepatectomy). Ensuring a graded response
to the level of mitogens is clearly of fundamental importance. A
priori, this requires either an inherently probabilistic response to
mitogenic stimuli, with probability proportional to the stimulus,
or the generation of actual differences between cells in the
threshold for response – or most likely both, as has been discussed
here. Uncovering all the mechanisms involved clearly remains an
important goal. In recent years, progress in understanding the
molecular details of critical cell cycle transitions within individual
cells has been impressive. There is now every reason to hope that
in the very near future, a full, molecular understanding of the
origins of the variability will be forthcoming.
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